دورية أكاديمية

NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity

التفاصيل البيبلوغرافية
العنوان: NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity
المؤلفون: Wojnowski, L., Kulle, B., Schirmer, M., Schlüter, G., Schmidt, A., Rosenberger, A., Vonhof, S., Bickeböller, H., Toliat, M., Suk, E., Tzvetkov, M., Kruger, A., Seifert, S., Kloess, M., Hahn, H., Loeffler, M., Nürnberg, P., Pfreundschuh, M., Trümper, L., Brockmöller, J., Hasenfuss, G.
المصدر: Circulation
سنة النشر: 2005
المجموعة: Max Planck Society: MPG.PuRe
الوصف: Background: A significant number of patients treated with anthracyclines develop cardiotoxicity (anthracycline-induced cardiotoxicity [ACT]), mainly presenting as arrhythmias (acute ACT) or congestive heart failure (chronic ACT). There are no data on pharmacogenomic predictors of ACT. Methods and Results: We genotyped participants of the German non-Hodgkin lymphoma study (NHL-B) who were followed up for the development of heart failure for a median of >3 years. Single-nucleotide polymorphisms (SNPs) were selected from 82 genes with conceivable relevance to ACT. Of 1697 patients, 55 developed acute and 54 developed chronic ACT (cumulative incidence of either form, 3.2%). We detected 5 significant associations with polymorphisms of the NAD(P)H oxidase and doxorubicin efflux transporters. Chronic ACT was associated with a variant of the NAD(P)H oxidase subunit NCF4 (rs1883112, -212A->G; symbols with right-pointing arrows, as edited?‘ odds ratio [OR], 2.5; 95% CI, 1.3 to 5.0). Acute ACT was associated with the His72Tyr polymorphism in the p22phox subunit (rs4673; OR, 2.0; 95% CI, 1.0 to 3.9) and with the variant 7508T->A (rs13058338; OR, 2.6; 95% CI, 1.3 to 5.1) of the RAC2 subunit of the same enzyme. In agreement with these results, mice deficient in NAD(P)H oxidase activity, unlike wild-type mice, were resistant to chronic doxorubicin treatment. In addition, acute ACT was associated with the Gly671Val variant of the doxorubicin efflux transporter multidrug resistance protein 1 (MRP1) (OR, 3.6; 95% CI, 1.6 to 8.4) and with the Val1188Glu-Cys1515Tyr (rs8187694-rs8187710) haplotype of the functionally similar MRP2 (OR, 2.3; 95% CI, 1.0 to 5.4). Polymorphisms in adrenergic receptors previously demonstrated to be predictive of heart failure were not associated with ACT. Conclusions: Genetic variants in doxorubicin transport and free radical metabolism may modulate the individual risk to develop ACT.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: http://hdl.handle.net/11858/00-001M-0000-0010-8558-1Test
الإتاحة: http://hdl.handle.net/11858/00-001M-0000-0010-8558-1Test
رقم الانضمام: edsbas.902D5922
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.902D5922
765
3
Academic Journal
academicJournal
764.67431640625
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.902D5922&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => http://hdl.handle.net/11858/00-001M-0000-0010-8558-1# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Wojnowski%2C+L%2E%22">Wojnowski, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Kulle%2C+B%2E%22">Kulle, B.</searchLink><br /><searchLink fieldCode="AR" term="%22Schirmer%2C+M%2E%22">Schirmer, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Schlüter%2C+G%2E%22">Schlüter, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Schmidt%2C+A%2E%22">Schmidt, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Rosenberger%2C+A%2E%22">Rosenberger, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Vonhof%2C+S%2E%22">Vonhof, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Bickeböller%2C+H%2E%22">Bickeböller, H.</searchLink><br /><searchLink fieldCode="AR" term="%22Toliat%2C+M%2E%22">Toliat, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Suk%2C+E%2E%22">Suk, E.</searchLink><br /><searchLink fieldCode="AR" term="%22Tzvetkov%2C+M%2E%22">Tzvetkov, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Kruger%2C+A%2E%22">Kruger, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Seifert%2C+S%2E%22">Seifert, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Kloess%2C+M%2E%22">Kloess, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Hahn%2C+H%2E%22">Hahn, H.</searchLink><br /><searchLink fieldCode="AR" term="%22Loeffler%2C+M%2E%22">Loeffler, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Nürnberg%2C+P%2E%22">Nürnberg, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Pfreundschuh%2C+M%2E%22">Pfreundschuh, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Trümper%2C+L%2E%22">Trümper, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Brockmöller%2C+J%2E%22">Brockmöller, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Hasenfuss%2C+G%2E%22">Hasenfuss, G.</searchLink> )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Circulation )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2005 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Max Planck Society: MPG.PuRe )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Background: A significant number of patients treated with anthracyclines develop cardiotoxicity (anthracycline-induced cardiotoxicity [ACT]), mainly presenting as arrhythmias (acute ACT) or congestive heart failure (chronic ACT). There are no data on pharmacogenomic predictors of ACT. Methods and Results: We genotyped participants of the German non-Hodgkin lymphoma study (NHL-B) who were followed up for the development of heart failure for a median of >3 years. Single-nucleotide polymorphisms (SNPs) were selected from 82 genes with conceivable relevance to ACT. Of 1697 patients, 55 developed acute and 54 developed chronic ACT (cumulative incidence of either form, 3.2%). We detected 5 significant associations with polymorphisms of the NAD(P)H oxidase and doxorubicin efflux transporters. Chronic ACT was associated with a variant of the NAD(P)H oxidase subunit NCF4 (rs1883112, -212A->G; symbols with right-pointing arrows, as edited?‘ odds ratio [OR], 2.5; 95% CI, 1.3 to 5.0). Acute ACT was associated with the His72Tyr polymorphism in the p22phox subunit (rs4673; OR, 2.0; 95% CI, 1.0 to 3.9) and with the variant 7508T->A (rs13058338; OR, 2.6; 95% CI, 1.3 to 5.1) of the RAC2 subunit of the same enzyme. In agreement with these results, mice deficient in NAD(P)H oxidase activity, unlike wild-type mice, were resistant to chronic doxorubicin treatment. In addition, acute ACT was associated with the Gly671Val variant of the doxorubicin efflux transporter multidrug resistance protein 1 (MRP1) (OR, 3.6; 95% CI, 1.6 to 8.4) and with the Val1188Glu-Cys1515Tyr (rs8187694-rs8187710) haplotype of the functionally similar MRP2 (OR, 2.3; 95% CI, 1.0 to 5.4). Polymorphisms in adrenergic receptors previously demonstrated to be predictive of heart failure were not associated with ACT. Conclusions: Genetic variants in doxorubicin transport and free radical metabolism may modulate the individual risk to develop ACT. )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => http://hdl.handle.net/11858/00-001M-0000-0010-8558-1 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => http://hdl.handle.net/11858/00-001M-0000-0010-8558-1 )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.902D5922 )
RecordInfo Array ( [BibEntity] => Array ( [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Wojnowski, L. ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Kulle, B. ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Schirmer, M. ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Schlüter, G. ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Schmidt, A. ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Rosenberger, A. ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Vonhof, S. ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Bickeböller, H. ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Toliat, M. ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Suk, E. ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Tzvetkov, M. ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Kruger, A. ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Seifert, S. ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Kloess, M. ) ) ) [14] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Hahn, H. ) ) ) [15] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Loeffler, M. ) ) ) [16] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Nürnberg, P. ) ) ) [17] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Pfreundschuh, M. ) ) ) [18] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Trümper, L. ) ) ) [19] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Brockmöller, J. ) ) ) [20] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Hasenfuss, G. ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2005 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-locals [Value] => edsbas ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Circulation [Type] => main ) ) ) ) ) ) )
IllustrationInfo